Innovex International, Inc.
NYSE:INVXOil & Gas Equipment & Services
-$0.92 today
- Market cap
- $1.67B
- Beta
- 0.82
- P/E (TTM)
- 33.5
- EPS (TTM)
- $0.75
Volume 0.46M
Average 0.43M
INVX Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Innovex International, Inc.NYSE: INVX
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables turns positive
Q3 FY2026 accounts payables was $0, compared with -$397K a year earlier. Trailing-twelve-month accounts payables was $10.62M.
Context
- Accounts payables amounted to 1.3% of revenue in FY2025, down 2.1 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $2.65M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (12.7M) USD
- Year-over-year change
- +43.2%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (12.7M) | +43.2% |
| FY2024 | 2024-12-31 | (22.34M) | -630.7% |
| FY2023 | 2023-12-31 | 4.21M | +75.1% |
| FY2022 | 2022-12-31 | 2.41M | -74.9% |
| FY2021 | 2021-12-31 | 9.57M | — |
Accounts Payables vs competitors
How INVX compares with its peers on the latest reported figures
- INVX's LTM Sep 2026 accounts payables of $10.62M is the 8th largest of the 11 companies compared; the peer median is $18.79M.
- Its year-over-year change of +134.0% is the 7th highest of 11, against a peer median of +233.6%.
- Accounts payables amounts to 1.0% of revenue for INVX, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1B | +326.1% | — | 2.7% | |
| LTM Sep 2026 | $224.88M | +38475.8% | — | 12.3% | |
| LTM Mar 2026 | $91.61M | +224.1% | — | 8.6% | |
| LTM Sep 2026 | $55M | +885.7% | — | 1.1% | |
| LTM Jun 2026 | $48.8M | -390.7% | — | 1.9% | |
| LTM Mar 2026 | $32.08M | +22.5% | — | 2.1% | |
| LTM Mar 2026 | $15.24M | -56.3% | — | 1.0% | |
| LTM Sep 2026 | $10.62M | +134.0% | — | 1.0% | |
| LTM Jun 2026 | $5.5M | +243.1% | +52.2% | 0.7% | |
| LTM Mar 2026 | $3.67M | +103.3% | — | 1.1% | |
| LTM Mar 2026 | $993K | +1812.1% | +88.8% | 0.5% | |
| Peer median (excluding INVX) | $18.79M | +233.6% | +70.5% | 1.5% | |
Competitors are the stored peer set for INVX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 9.85M | 63.28M | 604K | 140.33M | 83.3M |
| Depreciation & Amortization | 17.74M | 24.96M | 30.06M | 39.52M | 73.24M |
| Deferred Income Tax | (8.7M) | (6.71M) | (7.41M) | (4.6M) | 34.29M |
| Stock-Based Compensation | 703K | 907K | 0 | 13.25M | 13.8M |
| Change in Working Capital | (32.39M) | (79.63M) | (23.81M) | (4.7M) | 19.28M |
| Accounts Receivables | (27.11M) | (37.57M) | (29.08M) | 13.22M | 17.63M |
| Inventory | (13.95M) | (44.21M) | (28.64M) | 7.87M | 46.63M |
| Accounts Payables | 9.57M | 2.41M | 4.21M | (22.34M) | (12.7M) |
| Other Working Capital | (901K) | (265K) | 29.7M | (3.45M) | (32.28M) |
| Other Non-Cash Items | 10.78M | (8.61M) | 76.42M | (90.36M) | (33M) |
| Operating Cash Flow | (2.03M) | (5.81M) | 75.86M | 93.44M | 190.91M |
| Capital Expenditures | (6.44M) | (9.58M) | (15.49M) | (13.59M) | (35.13M) |
| Acquisitions (Net) | (22.2M) | (28.91M) | (53.51M) | 88.79M | (83.67M) |
| Purchases of Investments | 0 | (32.23M) | (48.87M) | 0 | 0 |
| Sales of Investments | 0 | 0 | 55.19M | 0 | 0 |
| Other Investing Activities | 6.58M | 33.2M | 47.39M | 3.25M | 100.06M |
| Investing Cash Flow | (22.06M) | (37.52M) | (32.43M) | 78.44M | (18.74M) |
| Debt Repayment | 10.38M | 44.3M | (44.96M) | (21.18M) | (32.96M) |
| Common Stock Issued | 0 | 0 | 0 | 3.33M | 0 |
| Common Stock Repurchased | (331K) | (1.29M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | (74.98M) | 0 |
| Other Financing Activities | 0 | (719K) | 393K | (10.24M) | (11.96M) |
| Financing Cash Flow | 10.05M | 42.29M | (44.57M) | (103.07M) | (44.92M) |
| Effect of Forex Changes | (145K) | (272K) | 118K | (2.94M) | 2.88M |
| Net Change in Cash | (14.18M) | (1.32M) | (1.01M) | 65.87M | 130.13M |
| Free Cash Flow | (8.47M) | (15.39M) | 60.38M | 79.85M | 155.78M |
Innovex International, Inc.
NYSE:INVX
Intrinsic Alpha fair value
Locked
Current Price
$23.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.